Summary.-A study instigated by the British Breast Group and involving 3 centres (Edinburgh, Glasgow and Liverpool) was carried out to compare 3 methods for the estimation of urinary hydroxyproline. No significant difference between the first and the second 24 h urine collection was found for each measure of urinary hydroxyproline, within laboratories and within patient groups. Reliable hydroxyproline studies can, therefore, be performed on one 24 h urine collection.
A NUMBER of clinical reports published in recent years (Guzzo et al., 1969; Cuschieri and Felgate, 1972;  Cuschieri, 1973; Roberts et al., 1975; Powles et al., 1975) have indicated the usefulness of urinary hydroxyproline, particularly in relation to the excretion of creatinine in the detection of spread of breast cancer to bone, and in monitoring the effects of treatment for advanced disseminated disease. In practice, there are certain factors which militate against the more widespread use of this test in the management of breast cancer. The most important of these relates to the measurement of urinary hydroxyproline (OHP) for which several procedures are available. Most of the methods involve hydrolysis with acid at l 20°C (pressure cooker) although a recent kit method (Hypronosticon test) uses amberlite-resin-catalysed hydrolysis.
It is evident, therefore, that standardization ofthe method ofestimationof urinary OHP is necessary before any large scale multicentre studies are instituted.
The aims of the study were as follows: (1) To compare methods of urinary hydroxyproline estimation. (2) To determine the most economic, practicable and reproducible method.
PATIENTS AND METHODS
Criteria for admission.-Patients included in the study had to have histologically proven breast cancer. They were not to be on hormonal therapy or chemotherapy at the time of testing. For the purpose of the study all patients had to be admitted to hospital, and entry into the study was restricted to patients in the pre-operative period or more than 15 days after surgery. patients and controls were on a 4-day gelatinfree diet. The urine was collected in bottles containing 8-0 g boric acid as a preservative. Details of the diet are shown in Table I . A 50 ml sample from each 24h collection was sent from each centre to the other 2 laboratories participating in the study.
Clinical data.-Height (bare feet) weight (nude) and volume of each 24h urine collection were used to express the data relating to the excretion of urinary hydroxyproline. A complete list of all medications was obtained for each patient.
Methods of estimation.-The urinary hydroxyproline was estimated in Liverpool by the modified Grant's semi-automated technique (Grant, 1964) Table  II . Within each centre, no significant difference was observed between the results of the first and second 24h urine collections. Comparison between centres showed no significant difference between the Grant and the Ellis/Goldberg method but both gave significantly higher X-ray-.-The raw data are shown in Table IV . Fourteen patients had elevated OHP by one or more methods. Again, there was reasonable correlation only between the results obtained by the Grant and Ellis/Goldberg methods. For the X-raygroup as a whole, the Ellis/Goldberg results were significantly higher than either the Grant or Hypronosticon data (P < 0*01).
Urinary creatinine
No significant differences were observed between the laboratories for the urinary creatinine values in both the control and patient groups. This study has shown that the distribution of OHP in a healthy female population is skewed. A good correlation was found between the data (especially after standardization) obtained by the Grant and the Ellis/Goldberg methods. The Hypronosticon results were more variable, and tended to discriminate least between the various groups. This method is based on resin-catalysed hydrolysis. However, the activity of the resin is dependent on the cation concentration in the urine, which is not a constant factor and may account for the variability of the results obtained by this method. Recovery rates with the Hypronosticon Kit method using prolylhydroxy-proline as an internal standard were found to vary from 30 to 82%.
No significant difference was observed for each measure of OHP, within laboratories and within patient groups, between the first and second 24h collection. Reliable hydroxyproline studies can therefore be performed on one properly collected 24h urine specimen, and this should ease the performance of the test.
The incidence of an elevated OHP in breast-cancer patients with negative Xrays was 11/44 (25%), 5/34 (15%), 8/34 (19%) for the Ellis/Goldberg, Hypronosticon and Grant methods respectively. Previous reports (Guzzo et al., 1969; Cuschieri and Felgate, 1972; Cuschieri, 1973; Roberts et al., 1975; Powles et al., 1975) have shown that the majority of patients with negative X-rays but with a persistent elevation of OHP subsequently develop radiologically demonstrable metastases. In the present study, the follow-up period has been too short to permit confirmation of the predictive value of elevated OHP in cases of breast cancer with negative X-rays.
In 
